A single cell sequencing approach to determine the heterogeneity, dynamics and cell fate decisions of retinal progenitor cells in vivo and in vitro

一种单细胞测序方法,用于确定体内和体外视网膜祖细胞的异质性、动态和细胞命运决定

基本信息

  • 批准号:
    BB/T004460/1
  • 负责人:
  • 金额:
    $ 116.85万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

Being told that you have a visual impairment that can't be treated can be difficult to accept but this is the burden that 285 million people worldwide must bear. 26% of global blindness is caused by dysfunction of the retina, which is the innermost, light sensitive tissue that lines the back of the eye and is vital for light sensing and image processing. Dysfunction of retina and subsequent vision loss can occur through the effect of faulty genes we inherit from our parents as well as the accumulation of damage and the effect of various diseases throughout our lives. Our ability to prevent and treat vision loss is closely linked to our knowledge of "how our retinas form" and when and what is likely to go wrong. Our retinas develop mostly before birth; hence the availability of tissue to study from this time period is very limited. My group is in a unique position to bridge this gap, having access to human retinas through close and well established collaborations with the Human Developmental Biology Resource, which collects samples from aborted embryos and fetuses with the mother's consent. We also have the advantage of creating in the lab three-dimensional structures called "retinal organoids", which resemble the formation of human retina during development and contain the key retinal cell types. Our aim is to use both of these unique resources to understand how and when the retina forms and the role of genes that cause loss of vision when faulty.Retina is a complex tissue and is composed of seven cell types: these emerge at different points during our development from a pool of progenitor cells, which in itself is heterogeneous with various subsets suggested to give rise to the different cell types in a concise progression through time. For this reason, it has been difficult to pinpoint the progenitor cells which give rise to all the cell types that make up the human retina with the traditional research methods that rely on studies of cell mixtures. Here we propose to use an important new technology called single cell analysis which allows us to look at which genes are turned on in each cell in the population. Gene expression at the single cell level is a very reliable tool for the precise categorisation of cells and allows us to identify types of cells that are not noticeable when looking under the microscope at their shape or position. We will use this as a first step to explore the molecular differences of individual retinal cells in both developing retinas and the retinal organoids generated in our lab. The use of advanced data analysis techniques will then allow us to build a catalogue of cell types and the genes that characterise them, to match the progenitors to the various cell types across development, to predict their ultimate fate and to assess how closely the lab generated retinal organoids mimic the development of human retina. Second, we will use the single cell sequencing data to reconstruct a lineage tree using bioinformatics tools. This approach organises cells in 'pseudo-time', predicting the order and mode in which cell fate decisions are made, enabling us to predict genes that occupy special positions around branch points of the tree. Third, we will apply a new approach, which allows us to correlate the gene expression profile of individual cells with their location in the retina, thus creating a spatial map of our retinas as they develop. This spatial map will allow us to validate the expression of key genes that are found near the branch points which may be important to understand the decision that progenitor cells make towards their final trip to become retinal cells. Finally, we will assess whether genes expressed around branch points play an active role in controlling cell fate decisions by manipulating their expression. The information will be available to all scientists and clinicians to help their understanding of retinal development and disease.
被告知患有无法治疗的视力障碍可能很难接受,但这是全世界2.85亿人必须承受的负担。26%的全球失明是由视网膜功能障碍引起的,视网膜是最内层的光敏组织,排列在眼睛的后部,对光传感和图像处理至关重要。视网膜功能障碍和随后的视力丧失可以通过我们从父母那里继承的错误基因的影响以及损伤的积累和我们一生中各种疾病的影响而发生。我们预防和治疗视力丧失的能力与我们对“视网膜如何形成”以及何时以及什么可能出错的知识密切相关。我们的视网膜主要在出生前发育;因此,从这一时期开始研究的组织的可用性非常有限。我的团队在弥合这一差距方面处于独特的地位,通过与人类发育生物学资源密切和良好的合作,可以获得人类视网膜,该资源在母亲同意的情况下收集流产胚胎和胎儿的样本。我们还具有在实验室中创建称为“视网膜类器官”的三维结构的优势,这些结构类似于人类视网膜在发育过程中的形成,并包含关键的视网膜细胞类型。我们的目标是利用这两种独特的资源来了解视网膜是如何形成的,以及何时形成的,以及当出现故障时导致视力丧失的基因的作用。视网膜是一种复杂的组织,由七种细胞类型组成:这些在我们发育过程中的不同时间点从祖细胞库中出现,其本身是异质的,具有各种亚群,这些亚群被认为在时间的简明进程中产生不同的细胞类型。由于这个原因,很难用依赖于细胞混合物研究的传统研究方法来确定产生构成人类视网膜的所有细胞类型的祖细胞。在这里,我们建议使用一种重要的新技术,称为单细胞分析,它使我们能够看到哪些基因在群体中的每个细胞中被打开。单细胞水平的基因表达是精确分类细胞的一个非常可靠的工具,使我们能够识别在显微镜下观察其形状或位置时不明显的细胞类型。我们将以此为第一步,探索发育中的视网膜和我们实验室产生的视网膜类器官中单个视网膜细胞的分子差异。使用先进的数据分析技术将使我们能够建立一个细胞类型和基因的目录,将祖细胞与发育过程中的各种细胞类型相匹配,预测它们的最终命运,并评估实验室产生的视网膜类器官模拟人类视网膜发育的程度。其次,我们将使用单细胞测序数据,使用生物信息学工具重建谱系树。这种方法在“伪时间”中组织细胞,预测细胞命运决定的顺序和模式,使我们能够预测占据树的分支点周围特殊位置的基因。第三,我们将应用一种新的方法,使我们能够将单个细胞的基因表达谱与它们在视网膜中的位置相关联,从而创建我们视网膜发育的空间图。这个空间图将使我们能够验证在分支点附近发现的关键基因的表达,这对于理解祖细胞在最终成为视网膜细胞的过程中做出的决定可能很重要。最后,我们将评估基因表达周围的分支点发挥积极作用,通过操纵他们的表达控制细胞命运的决定。这些信息将提供给所有科学家和临床医生,以帮助他们了解视网膜发育和疾病。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Incorporating microglia-like cells in human induced pluripotent stem cell-derived retinal organoids.
Human Retinal Organoids Provide a Suitable Tool for Toxicological Investigations: A Comprehensive Validation Using Drugs and Compounds Affecting the Retina.
  • DOI:
    10.1093/stcltm/szab010
  • 发表时间:
    2022-03-17
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Dorgau B;Georgiou M;Chaudhary A;Moya-Molina M;Collin J;Queen R;Hilgen G;Davey T;Hewitt P;Schmitt M;Kustermann S;Pognan F;Steel DH;Sernagor E;Armstrong L;Lako M
  • 通讯作者:
    Lako M
Deciphering the spatio-temporal transcriptional and chromatin accessibility of human retinal organoid development at the single cell level
在单细胞水平上破译人类视网膜类器官发育的时空转录和染色质可及性
  • DOI:
    10.1101/2023.07.19.549507
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dorgau B
  • 通讯作者:
    Dorgau B
Spatial transcriptomics of human pluripotent stem cell derived retinal organoids offers new insight in retinal development
人类多能干细胞来源的视网膜类器官的空间转录组学为视网膜发育提供了新的见解
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Majlinda Lako其他文献

Animal Models for Limbal Stem Cell Deficiency: A Critical Narrative Literature Review
  • DOI:
    10.1007/s40123-023-00880-0
  • 发表时间:
    2024-01-27
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Eray Atalay;Burcugül Altuğ;Mert Egemen Çalışkan;Semih Ceylan;Zeynep Serra Özler;Gustavo Figueiredo;Majlinda Lako;Francisco Figueiredo
  • 通讯作者:
    Francisco Figueiredo
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity
多能干细胞衍生的视网膜疾病模型:阐明发病机制、评估新疗法和评估毒性
  • DOI:
    10.1016/j.preteyeres.2024.101248
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    14.700
  • 作者:
    Marzena Kurzawa-Akanbi;Nikolaos Tzoumas;Julio C. Corral-Serrano;Rosellina Guarascio;David H. Steel;Michael E. Cheetham;Lyle Armstrong;Majlinda Lako
  • 通讯作者:
    Majlinda Lako
Unravelling genotype-phenotype correlations in Stargardt disease using patient-derived retinal organoids
利用患者来源的视网膜类器官解开斯特格病中的基因型-表型相关性
  • DOI:
    10.1038/s41419-025-07420-7
  • 发表时间:
    2025-02-19
  • 期刊:
  • 影响因子:
    9.600
  • 作者:
    Avril Watson;Rachel Queen;Luis Ferrández-Peral;Birthe Dorgau;Joseph Collin;Andrew Nelson;Rafiqul Hussain;Jonathan Coxhead;Michael McCorkindale;Robert Atkinson;Darin Zerti;Valeria Chichagova;Ana Conesa;Lyle Armstrong;Frans P. M. Cremers;Majlinda Lako
  • 通讯作者:
    Majlinda Lako

Majlinda Lako的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Majlinda Lako', 18)}}的其他基金

Off-the-shelf hypoimmunogenic photoreceptors for treatment of blinding retinal disease
现成的低免疫原性光感受器用于治疗致盲性视网膜疾病
  • 批准号:
    EP/Y031016/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
To assess the engraftment of hESC-derived photoreceptors and their ability to restore vision in early and advanced stages of Retinitis Pigmentosa.
评估 hESC 来源的光感受器的植入及其在色素性视网膜炎早期和晚期恢复视力的能力。
  • 批准号:
    MR/X001687/1
  • 财政年份:
    2023
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
Elucidating splicing factor function and retinal splicing programmes: developing new therapeutic strategies for splicing factor retinitis pigmentosa
阐明剪接因子功能和视网膜剪接方案:开发剪接因子色素性视网膜炎的新治疗策略
  • 批准号:
    MR/T017503/1
  • 财政年份:
    2020
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
Assessing SARS-CoV-2 entry, replication and prevention in a primary human conjunctival cell model and organ cultured cornea/conjunctiva.
评估原代人类结膜细胞模型和器官培养角膜/结膜中 SARS-CoV-2 的进入、复制和预防。
  • 批准号:
    BB/V01126X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
Understanding the molecular and cellular complexity of human cornea through single cell analyses
通过单细胞分析了解人类角膜的分子和细胞复杂性
  • 批准号:
    MR/S035826/1
  • 财政年份:
    2018
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
Using zinc finger nuclease technology to generate reporter-labelled human pluripotent stem cells as a tool to optimize photoreceptor transplantation
使用锌指核酸酶技术生成报告基因标记的人类多能干细胞作为优化光感受器移植的工具
  • 批准号:
    BB/I02333X/1
  • 财政年份:
    2011
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant
A state of the art multiparametric flow cytometry analysis system for multidisciplinary stem cell research
用于多学科干细胞研究的最先进的多参数流式细胞术分析系统
  • 批准号:
    BB/E012841/1
  • 财政年份:
    2007
  • 资助金额:
    $ 116.85万
  • 项目类别:
    Research Grant

相似国自然基金

全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    15.0 万元
  • 项目类别:
    省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
  • 批准号:
    82305053
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 批准年份:
    2023
  • 资助金额:
    46.00 万元
  • 项目类别:
    面上项目
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
  • 批准号:
    82370923
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目

相似海外基金

Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
  • 批准号:
    10590033
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
Developmental mechanisms specifying vagal innervation of organ targets
指定器官目标迷走神经支配的发育机制
  • 批准号:
    10752553
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
  • 批准号:
    10752276
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
  • 批准号:
    10752508
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
  • 批准号:
    10751872
  • 财政年份:
    2024
  • 资助金额:
    $ 116.85万
  • 项目类别:
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 116.85万
  • 项目类别:
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 116.85万
  • 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 116.85万
  • 项目类别:
Regulation of prostate organogenesis by tissue-resident macrophages
组织驻留巨噬细胞对前列腺器官发生的调节
  • 批准号:
    10555589
  • 财政年份:
    2023
  • 资助金额:
    $ 116.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了